Pseudoresistant hypertension attributed to white-coat effect

Hypertension

Volumn 59, Issue 3, 2012, Pages 532-533

  Myers, Martin G ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DIAGNOSTIC ERROR; DIASTOLIC BLOOD PRESSURE; HOME MONITORING; HUMAN; HYPERTENSION; NOTE; PRIORITY JOURNAL; PSEUDORESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; WHITE COAT HYPERTENSION;

BLOOD PRESSURE; HUMANS; POPULATION SURVEILLANCE; WHITE COAT HYPERTENSION;

EID: 84857625550     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.189472     Document Type: Note

References (11)

1. Ayman D, Goldshine AD. Blood pressure determination by patients with essential hypertension: 1-the difference between clinic and home readings before treatment. Am J Med Sci. 1940;200:465-474.
2. Sokolow M, Werdegar D, Kain HK, Hinman AT. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation. 1966;34: 279-298.
3. Floras JS, Jones JV, Hassan MO, Osikowska B, Sever PS, Sleight P. Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet. 1981;2:107-109. (Pubitemid 11074960)
4. Pickering TG, Harshfield GA, Kleinert HD, Laragh JH. Ambulatory monitoring in the evaluation of blood pressure in patient with borderline hypertension and the role of the defense reflex. J Clin Exp Hypertens. 1982;A4:675-693. (Pubitemid 12025376)
5. Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH. Comparisons of blood pressure during normal daily activities, sleep, and exercise in normal and hypertensive subjects. JAMA. 1982;247:992-996. (Pubitemid 12162302)
6. Kleinert HD, Harshfield GA, Pickering TG, Devereux RB, Sullivan PA, Marion RM, Mallory WK, Laragh JH. What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension. 1984;6:574-578. (Pubitemid 14067814)
7. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259:225-228. (Pubitemid 18026263)
8. Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens. 1991;4:844-849.
9. National Institute for Health and Clinical Excellence: Hypertension. NICE Clinical Guidelines 127. National Clinical Guidelines Centre, London, UK, August, 2011.
10. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, Björklund- Bodegrd K, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA, on behalf of the International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012;59:564-571.
11. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment-a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-1419.